Executives On The Move: AVEO Pharmaceuticals, Everest Medicines and More
Recent executive changes in the industry include C-suite changes at Aveo Pharmaceuticals and Scandion Oncology. Meanwhile, new directors were appointed at Akston Biosciences and Everest Medicines.
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
In accepting Scrip’s Lifetime Achievement Award, Ovid Therapeutics’ CEO called on pharma to show responsible leadership and live up to its potential to do good for society.
Recent moves in the industry include internal rejigs at Homology Medicines, Virpax Pharmaceuticals, CytoDyn and Applied Therapeutics, plus new board members at Neuroscientific Biopharmaceuticals.